PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.83%
Net income growth under 50% of MRVL's 85.49%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
2.43%
Some D&A expansion while MRVL is negative at -3.63%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
1300.00%
Well above MRVL's 313.53% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-27.54%
Both cut yoy SBC, with MRVL at -4.47%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
336.76%
Well above MRVL's 22.63% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-785.71%
AR is negative yoy while MRVL is 54.48%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-132.50%
Both reduce yoy inventory, with MRVL at -18033.33%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
305.88%
A yoy AP increase while MRVL is negative at -84.58%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
339.29%
Growth well above MRVL's 163.64%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
108.77%
Some yoy increase while MRVL is negative at -92.88%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
14.47%
Operating cash flow growth similar to MRVL's 14.04%. Walter Schloss would see parallel improvements or market conditions in cash generation.
-25.91%
Both yoy lines negative, with MRVL at -79.78%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
25.91%
Acquisition growth of 25.91% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
13.27%
Purchases growth of 13.27% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-46.44%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-34.57%
Both yoy lines negative, with MRVL at -1500.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-796.06%
Both yoy lines negative, with MRVL at -82.39%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
38.89%
Issuance growth of 38.89% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
4.79%
We have some buyback growth while MRVL is negative at -2.77%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.